Epigenetics Market: What are the opportunities in Pharma & Biotech industry in 2019
The global epigenetics market is projected to reach $1.60 billion by 2022, at a CAGR of 13.3% from 2017 to 2022.
(EMAILWIRE.COM, December 21, 2018 ) According to a new market research report "Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) - Global Forecast to 2022", published by MarketsandMarkets™, the market is projected to reach USD 1,605.7 million by 2022 from an estimated USD 854.0 million in 2017, at a CAGR of 13.5% during the forecast period.
The growth in this market is primarily attributed to decreasing sequencing costs, increasing research activity, funding for epigenetics research, rising prevalence of cancer and growing applications of epigenetics in non-oncology diseases. Expanding application areas of epigenetics in non-oncology diseases, personalized medicine, and target therapy are expected to provide growth opportunities for players operating in the epigenetics market in the coming years.
Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=896
According to a press release published by the Tufts Center for the Study of Drug Development in May 2015, biopharmaceutical companies have nearly doubled their R&D investments in personalized medicine over the last five years, and these investments are further expected to increase by 33% over the next five years. This will further drive the use of epigenetics tools.
Emerging markets such as Brazil, China, and India offer significant growth potential to market players. This can primarily be attributed to the diversified healthcare market in this region, growing incidence of infectious and chronic disorders, and increasing R&D initiatives targeted at the development of innovative genomic techniques.
Avail Discount on Report:
https://www.marketsandmarkets.com/discountreports.asp?id=896
Oncology is one of those applications where epigenetics technology is extensively used for deriving therapeutic strategies designed to reverse transcriptional abnormalities inherent to the cancer epigenome. The disruption of epigenetic modifications, such as DNA methylation and histone modification, results in altered gene function or expression and cellular transformation leading cancer.
Get Free 10% Customization on Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=896
Media Contact
- Mr. Shelly Singh
- sales@marketsandmarkets.com